Novavax’s stock pops after WHO grants its COVID-19 vaccine emergency-use listing
Published
Novavax Inc.’s stock rose 2% early Tuesday, after the company said its protein-based COVID-19 vaccine has been granted emergency-use listing by the World Health Organization. The move means that all 194 of the agency’s member states can use the Novavax vaccine to protect against COVID in…
#novavaxincs